GalenOps prod · 0.1.0

Settings

Demo visibility. Hidden trials disappear from every screen in the console, the field app and Luna — dashboards, queues, sites, patients, safety, agents and Luna users — until you show them again.

Trials 21

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
Phase II completed
A Phase 1 Study to Evaluate Intratumoral Doxorubicin Exposure Following Administration of Aldoxorubicin or Doxorubicin
Phase I startup
A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III active
ADCElerate1: ADCE-D01 (uPARAP ADC) in advanced soft tissue sarcoma
Phase I/II recruiting
ADCLARA-01 ADCLARA-01: SOT106 (LRRC15 ADC) in LRRC15-positive osteosarcoma and STS
Phase I/II not_yet_recruiting
AGX101 (TM4SF1 ADC) in advanced solid tumours incl. angiosarcoma
Phase I recruiting
AL58805 with AL8326, eribulin or fulvestrant in gynaecological cancers, STS and breast
Phase Ib/IIa not_yet_recruiting
APROMISS: catequentinib (AL3818) in ASPS, leiomyosarcoma and synovial sarcoma
Phase III recruiting
ATLAS: [225Ac]RTX-2358 (FAP radioligand) in relapsed or refractory soft tissue sarcoma
Phase I/II recruiting
Afamitresgene autoleucel (MAGE-A4 TCR-T) Phase 1 dose escalation
Phase I active_not_recruiting
Catequentinib alone or with AL58805, temozolomide or CCNU (incl. STS cohorts)
Phase Ib/IIa not_yet_recruiting
HH2853-G101: EZH1/2 inhibitor in r/r NHL and advanced solid tumours incl. epithelioid sarcoma
Phase I/II recruiting
Luca-1: SHY-ONC6 (19S proteasome ATPase inhibitor) in advanced solid tumours
Phase Ia/Ib recruiting
PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Trial With an Open-label Extension of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder and PTSD
Phase II active Hidden
QB46C-H07: intratumoural tigilanol tiglate in advanced soft tissue sarcoma
Phase IIa recruiting
SPEARHEAD-1 SPEARHEAD-1: afamitresgene autoleucel in advanced synovial sarcoma and MRCLS
Phase II active_not_recruiting
SPEARHEAD-3 SPEARHEAD-3: afamitresgene autoleucel paediatric basket
Phase I/II recruiting
ST-01156 ST-01156-101: RBM39 molecular glue degrader in advanced solid tumours incl. Ewing sarcoma
Phase I/Ib recruiting
STC-15 STC-15 (METTL3 inhibitor) with toripalimab, and as monotherapy in selected sarcomas
Phase Ib/II recruiting
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II completed Hidden
ZL-6201 ZL-6201-001: LRRC15 ADC in sarcoma and selected epithelial solid tumours
Phase Ia/Ib recruiting
Hiding is a display setting only: the trial's data stays in place and its agent runs continue underneath. The choice is stored on the backend, so it applies to every browser and app.